PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Cerebral and tissue oximeters: Analysis of approved products • Description about some key devices PART 06: Cost and benefit analysis of cerebral and tissue oximeters • Cost and benefit analysis of INVOUS tissue oximeter PART 07: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 08: Geographical segmentation • Cerebral and tissue oximetry devices market in Americas • Cerebral and tissue oximetry devices market in EMEA • Cerebral and tissue oximetry devices market in APAC PART 09: Market drivers • Incidence of cerebral hypoxia • Incorporation of near-infrared spectroscopy • Monitoring intraventricular hemorrhage PART 10: Impact of drivers PART 11: Market challenges • Limitations of available cerebral oximeters • Stringent regulatory framework • Unfavorable reimbursement scenario PART 12: Impact of drivers and challenges PART 13: Market trends • Development of multi-parameter oximeters • Product approvals • Distribution agreements PART 14: Vendor landscape • Competitive scenario • Key vendors • Other prominent vendors PART 15: Appendix • List of abbreviations PART 16: Explore Technavio   Exhibit 01: Product offerings Exhibit 02: Key 510(k) FDA-approved cerebral and tissue oximeters Exhibit 03: Cost savings for cardiac surgeries that involved INVOUS tissue oximeter Exhibit 04: Global cerebral and tissue oximetry devices market 2015-2020 ($ millions) Exhibit 05: Five forces analysis Exhibit 06: Global cerebral and tissue oximetry devices market segmentation by geography 2015 Exhibit 07: Global cerebral and tissue oximetry devices market segmentation by geography 2020 Exhibit 08: Global cerebral and tissue oximetry devices market segmentation by geography 2015-2020 Exhibit 09: Global cerebral and tissue oximetry devices market segmentation by geography 2015-2020 ($ millions) Exhibit 10: Cerebral and tissue oximetry devices market in Americas 2015-2020 ($ millions) Exhibit 11: Cerebral and tissue oximetry devices market in EMEA 2015-2020 ($ millions) Exhibit 12: Cerebral and tissue oximetry devices market in APAC 2015-2020 ($ millions) Exhibit 13: Impact of drivers Exhibit 14: Impact of drivers and challenges Exhibit 15: CAS Medical Systems: Business segmentation by revenue 2014 Exhibit 16: CAS Medical Systems: Business segmentation by revenue 2013 and 2014 ($ millions) Exhibit 17: CAS Medical Systems: Revenue of tissue oximetry monitoring segment 2014 Exhibit 18: CAS Medical Systems: Revenue of tissue oximetry monitoring segment by region 2014 Exhibit 19: CAS Medical Systems: Geographical segmentation by revenue 2014 Exhibit 20: CAS Medical Systems: Key takeaways Exhibit 21: Masimo: Business segmentation by revenue 2016 Exhibit 22: Masimo: Business segmentation by revenue 2015 and 2016 ($ millions) Exhibit 23: Masimo: Key takeaways Exhibit 24: Medtronic: Product offerings Exhibit 25: Medtronic: Key takeaways Exhibit 26: Nonin Medical: Key takeaways Exhibit 27: Other prominent vendors

CAS Medical Systems Inc., Masimo Corp., Medtronic plc, Nonin Medical Inc, Hamamatsu Photonics, Hutchinson Technology, HyperMed, ISS, Moor Instruments, Ornim Medical, Reflectance Medical, Spectros, ViOptix.